Researchers have enhanced agene therapy approach for children with adenosine deaminase-deficient severe combined immunodeficiency using chemotherapy as conditioning regimen. For the first time, investigators test two different viral vectors to transport normal genes into the young patients' bone marrow stem cells and two different treatment plans in preparation for receiving gene therapy and ...
